UBS O'Connor’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-42,819
| Closed | -$432K | – | 382 |
|
|
2025
Q1 | $432K | Sell |
42,819
-136,447
| -76% | -$1.38M | 0.01% | 206 |
|
|
2024
Q4 | $2.12M | Buy |
179,266
+32,329
| +22% | +$382K | 0.06% | 146 |
|
|
2024
Q3 | $1.7M | Buy |
146,937
+22,720
| +18% | +$262K | 0.04% | 194 |
|
|
2024
Q2 | $1.31M | Buy |
124,217
+27,000
| +28% | +$285K | 0.04% | 255 |
|
|
2024
Q1 | $1.02M | Sell |
97,217
-101,215
| -51% | -$1.07M | 0.03% | 268 |
|
|
2023
Q4 | $2.23M | Buy |
198,432
+34,221
| +21% | +$384K | 0.07% | 156 |
|
|
2023
Q3 | $1.92M | Sell |
164,211
-26,000
| -14% | -$304K | 0.03% | 250 |
|
|
2023
Q2 | $1.92M | Buy |
190,211
+28,386
| +18% | +$286K | 0.04% | 301 |
|
|
2023
Q1 | $1.19M | Buy |
+161,825
| New | +$1.19M | 0.03% | 383 |
|